5th World Congress on Cancer Therapy
Holy Stone Healthcare Co., Ltd., Taiwan
Eskouhie Tchaparian is currently director of translational and clinical research at HolyStone Healthcare Inc. (HSHC). She has more than 15 years experience of academic and biotechnology research both in preclinical and clinical areas. Prior to joining HSHC, Tchaparian was a researcher at Bioengineering and Therapeutic Sciences department, University of California, San Francisco, and worked at Amgen where she held positions of increasing responsibility in multidisciplinary research activities. She has authored or co-authored over 40 research papers, abstracts, or book chapters. Tchaparian received her Master’s and PhD. in Nutritional Biology/physiology and metabolism from University of California, Davis.